ATProto Browser

Record data

{
  "uri": "at://did:plc:galrfhr7saafpmgsibeec6og/app.bsky.feed.post/3ldbertgwak23",
  "cid": "bafyreifssdf3gdk3c3f6czrwnwtxx65trhezthpzelhgipjne7slatcqou",
  "value": {
    "text": "In wake of McKinsey's $650 million settlement with the government for its role advising opioid companies, read our story from nearly six years ago on how the company helped Purdue Pharma www.propublica.org/article/oxyc...",
    "$type": "app.bsky.feed.post",
    "embed": {
      "$type": "app.bsky.embed.external",
      "external": {
        "uri": "https://www.propublica.org/article/oxycontin-purdue-pharma-massachusetts-lawsuit-anti-addiction-market",
        "thumb": {
          "$type": "blob",
          "ref": {
            "$link": "bafkreife46hbmx22m43ejyehojvcsz5gppc6mpfcmajau6jc2muzwlryha"
          },
          "mimeType": "image/jpeg",
          "size": 306368
        },
        "title": "OxyContin Maker Explored Expansion Into “Attractive” Anti-Addiction Market",
        "description": "Secret portions of a lawsuit allege that Purdue Pharma, controlled by the Sackler family, considered capitalizing on the addiction treatment boom — while going to extreme lengths to boost sales of its..."
      }
    },
    "langs": [
      "en"
    ],
    "facets": [
      {
        "index": {
          "byteEnd": 221,
          "byteStart": 187
        },
        "features": [
          {
            "uri": "https://www.propublica.org/article/oxycontin-purdue-pharma-massachusetts-lawsuit-anti-addiction-market",
            "$type": "app.bsky.richtext.facet#link"
          }
        ]
      }
    ],
    "createdAt": "2024-12-14T13:11:30.978Z"
  }
}